Akari Therapeutics PlcのROCE
Akari Therapeutics PlcのROCEは何ですか。
Akari Therapeutics PlcのROCEは-220.95%です。
ROCEの定義は何ですか。
使用資本利益率(ROCE)は、企業の収益性とその資本が使用される効率を測定する財務比率です。
Return on capital employed (ROCE) is the total amount of capital that a company has utilized in order to generate profits. It is the sum of shareholders' equity and debt liabilities. It can be simplified as total assets minus current liabilities.
ROCE is especially useful when comparing the performance of companies in capital-intensive sectors. ROCE considers debt and other liabilities as well compared to other fundamentals which only analyze profitability related to a company’s common equity. This provides a better indication of financial performance for companies with significant debt. For a company, the ROCE trend over the years is also an important indicator of performance. In general, investors tend to favor companies with stable and rising ROCE numbers over companies where ROCE is volatile and bounces around from one year to the next.
Instead of using capital employed at an arbitrary point in time, analysts and investors often calculate ROCE based on the average capital employed (ROACE), which takes the average of opening and closing capital employed for the time period.
NASDAQのセクタHealth CareにおけるROCEの企業と比べるAkari Therapeutics Plc
Akari Therapeutics Plcは何をしますか。
akari is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics to treat orphan autoimmune and inflammatory diseases. akari’s lead drug, coversin, a second-generation and potentially best-in-class complement inhibitor, acts on complement component-c5, preventing release of c5a and formation of c5b – 9 (also known as the membrane attack complex or mac). coversin is a recombinant small protein (16,740 da) derived from a native protein discovered in the saliva of the ornithodoros moubata tick, where it modulates the host immune system to allow the parasite to feed without alerting the host to its presence or provoking an immune response.
Akari Therapeutics Plcと類似のroce
- BioCardiaのROCEは-224.64%です。
- Sunworks IncのROCEは-223.47%です。
- Soligenix IncのROCEは-223.00%です。
- Katoro Gold plcのROCEは-222.81%です。
- DelMar PharmaceuticalsのROCEは-222.47%です。
- Applied TherapeuticsのROCEは-222.43%です。
- Akari Therapeutics PlcのROCEは-220.95%です。
- Dore Copper MiningのROCEは-220.90%です。
- Applied Genetic Technologies CorpのROCEは-219.90%です。
- IntrusionのROCEは-219.55%です。
- Galera Therapeutics IncのROCEは-218.63%です。
- Lumos Pharma IncのROCEは-217.72%です。
- AutoWeb IncのROCEは-217.47%です。